Posts

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Industry : Market Development, Analysis and Overview 2017

ResearchMoz presents professional and in-depth study of "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment".

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 270 tables & figures over 254 pages. The personalized medicine (global) market is presented as follows:

    By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)
    By Geography (US, UK, EU)
    By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services)
    By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)

A wealth of financial data & business strategy information is provided including:

    Compa…

Development of Diagnostic Reagent Industry in China : Overview, Size and Share 2017

ResearchMoz presents professional and in-depth study of "Research on China Diagnostic Reagent Industry, 2015".

After 30 years of development, the China'sdiagnostic reagent industry achieved a market size of nearly RMB 20 billion in 2014, a YoY growth of 15.7%. Currently nearly 90% downstream users of China's diagnostic reagent market comes from hospitals.

There's still a huge growth potential in China's diagnostic reagent industry. China accounts for 20% of total population worldwide, but only take up 7% of global diagnostic reagent market in 2014. The average diagnostic reagent expense in China is only around $3, far below the average of $28 in the developed countries.

Currently there are about 300 diagnostic reagent enterprises in China and the industry concentration is still low. Large companies in China include: KHB, Da An Gene, Maker, HTA etc. Foreign brands accounts for over 50% of China's diagnostic reagent market in 2014, especially in high-end field…

Analysis of Veterinary Diagnostic Market in Global and Chinese Industry : Market Development and Overview 2017

ResearchMoz presents professional and in-depth study of "Outlook of Global and Chinese Veterinary Diagnostic Industry 2015-2020".

The currentveterinary diagnostics market is largely characterized through the U.S. companion animal diagnostics market and European food animal diagnostics market. Companion animal diagnostics in Europe, rest of world companion diagnostics and food animal infectious disease diagnostics represent submarkets with significant potential for growth, also Chinese market.

International trade, public health, agricultural productivity, consumer confidence and companion animal-owner relationships are all dependent upon effective and increasingly specialized veterinary diagnostics products. Expertise in molecular diagnostics, virology and bacteriology is crucial in the food animal diagnostics space as emergent threats and outbreaks necessitate the development and improvement of assays for newly implemented disease control programs.

Table Of Contents

I VETERINARY…

Research of Cord Blood Banking Market in Global Industry : Trends, Analysis, Growth and Status 2017

ResearchMoz presents professional and in-depth study of "Complete 2015-16 Global Cord Blood Banking Industry Report".

The global cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities. Serious threats to the industry include:

    New accreditation requirements that have increased the cost structure of cord blood banks
    A decline in cord blood transplants in 2013, within the U.S. and other geographical regions
    Low rates of turnover for stored cord blood units
    Expensive cord blood transplantation procedures, costing from $200-300K each
    Difficulty with educating obstetricians about cellular therapies
    Poor press coverage in many regions worldwide, including major news outlets

Other uncontrollable factors that could threaten the industry include: new legislation, changes in transplant reimbursement, continually evolving accreditation requirements, the potential for competitive approaches to b…

Insights of Blood Coagulation Factor Inhibitors Industry : Trends, Analysis, Growth and Status 2017

ResearchMoz presents professional and in-depth study of "Blood Coagulation Factor Inhibitors - Pipeline Insights, 2015".

DelveInsight’s,Blood Coagulation Factor Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Blood Coagulation Factor Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Blood Coagulation Factor Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight’s, Blood Coagulation Factor Inhibitors- Pipeline Insights, 2015 Report covers the Blood Coagulation Factor Inhibitors pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides …

Market Insight : Cardiac Resynchronization Theapy Devices Market in Europe Grow at a CAGR of 8.09% by Revenue During the Forecast Period 2017-2019

ResearchMoz presents professional and in-depth study of "Cardiac Resynchronization Theapy Devices Market in Europe 2015 - 2019".

According to WHO, cardiovascular diseases accounted for more than half of all deaths in the European region. The annual overall cost of cardiovascular diseases in the top five European countries is estimated to be $90.10 billion, of which 54% is attributed to healthcare costs, 24% to loss in productivity, and 22% to informal care.
CRT devices are implantable devices that are used to resynchronize contractions of the hearts ventricles by sending tiny electrical impulses to the muscles of the heart. CRT is an effective therapy for patients suffering from heart failure and arrhythmias.

Technavio's analysts forecast the cardiac resynchronization therapy devices market in Europe to grow at a CAGR of 8.09% over the period 2014-2019.

Covered in this Report
The report includes the present scenario and the growth prospects of the cardiac resynchronization th…

Contraceptive Devices Market Globally Grow at a CAGR of 4.88% by 2019

ResearchMoz presents professional and in-depth study of "Global Contraceptive Devices Market 2015-2019".

Contraception methods can be temporary or permanent and are available for both men and women. Permanent methods include sterilization for women (tubal occlusion or hysteroscopy) and sterilization for men (vasectomy). Temporary methods are hormonal and non-hormonal. Hormonal methods include contraceptive transdermal patches, oral contraceptive pills, hormonal IUDs, vaginal rings, and vaginal implants. Non-hormonal methods include withdrawal methods, diaphragms, condoms, sponges, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods.

Technavio's analysts forecast the global contraceptive devices market to grow at a CAGR of 4.88% over the period 2014-2019.

Covered in this Report
The report includes the present scenario and the growth prospects of the global contraceptive devices market for …